
Article 1 

1. The Community shall undertake a technical study aiming at estimating across the European Union the prevalence of Salmonella spp. in flocks of laying hens (Gallus gallus) for table egg production at the end of their production period (hereafter the study).
2. The results shall be used to set Community targets as provided for in Article 4 of Regulation (EC) No 2160/2003.
3. The study shall cover a one-year period commencing from 1 October 2004.
4. For the purpose of this decision ‘competent authority’ shall mean the authority or authorities of a Member State as provided for in Article 3 of Regulation (EC) No 2160/2003.
5. For the purpose of paragraph 1, the Commission and the Member States shall cooperate in accordance with Articles 2 to 6.
Article 2 

1. Sampling for the purpose of carrying out the study shall be organised by the Member States and shall be performed from 1 October 2004 in holdings containing at least 1 000 laying hens. Where appropriate, smaller holdings shall also be sampled according to the technical specifications referred to in Article 5, focusing preferably on holdings with more than 350 hens.
2. In each selected holding, one flock with hens of the appropriate age shall be sampled.
3. Sampling shall be performed by the competent authority or under its supervision, by bodies to which it has delegated this responsibility.
4. At least 172 holdings shall be sampled in each Member State. However, in Member States where fewer than 172 holdings exist all holdings shall be sampled. In all cases, priority shall be given to the sampling of holdings with more than 1 000 hens.
Article 3 

1. Detection and serotyping shall take place in national reference laboratories for salmonella.
2. By derogation from paragraph 1, in case the national reference laboratory does not have the capacity to perform all analyses or if it is not the laboratory that performs detection routinely, the competent authorities may decide to designate a limited number of other laboratories involved in official control of salmonella to perform the analyses. These laboratories shall have proven experience of using the required detection method, shall implement a quality assurance system complying with ISO standard 17025, and shall be submitted to the supervision of the national reference laboratory.
3. The detection of Salmonella spp shall be performed in accordance with the method recommended by the Community reference laboratory for salmonella.
4. Serotyping shall be performed according to the Kaufmann-White scheme.
Article 4 

1. The national authority responsible for the preparation of the yearly national report on the monitoring of salmonella in animals pursuant to Article 9 of Directive 2003/99/EC shall collect and evaluate the results of the detection achieved pursuant to Article 3 on the basis of the sampling frame referred to in Article 2, and shall report its evaluation to the Commission.
2. All relevant data collected for the purpose of the study shall be supplied to the European Food Safety Authority, upon request from the Commission.
3. National aggregated data and results will be made available publicly in a form that ensures confidentiality.
Article 5 
The tasks and activities referred to in Articles 3 to 4 of this decision shall be performed in conformity with the technical specifications that have been presented at the meeting of the Standing Committee on the Food Chain and Animal Health on 15 July 2004, as published on the Commission website.
Article 6 

1. The Community shall provide financial assistance for certain costs incurred by the member States for laboratory testing, i.e. bacteriological detection of Salmonella spp. and serotyping of the relevant isolates.
2. The maximum financial assistance from the Community shall be EUR 20 per test for bacteriological detection of Salmonella spp. and 30 EUR for serotyping of the relevant isolates.
3. The financial assistance from the Community shall not exceed the amounts established in Annex I for the duration of the study.
Article 7 

1. The financial assistance referred to under Article 6 shall be granted to each Member State provided that the implementation of the study is in conformity with the relevant provisions of Community law, including rules on competition and on award of public contracts, and subject to the conditions provided for in points (a) to (d) being respected.
(a) Bringing into force by 1 October 2004, as appropriate the laws, regulations and administrative provisions for implementing the study.
(b) Forwarding a progress report covering the first 3 months of the study, at the latest four weeks after the end of the reporting period.
(c) Forwarding a final report by 15 October 2005 at the latest on the technical execution of the study accompanied by justifying evidence as to the costs incurred and the results attained during the period from 1 October 2004 to 30 September 2005. The evidence as to costs incurred shall contain at least the information set out in the Annex II.
(d) Implementing the study effectively.
2. A prefinancing of 50 % of the total amount may be paid at the request of each Member State.
3. Failure to comply with the time limit in subparagraph 1(c), shall imply a progressive and cumulative reduction of the financial contribution by 25 % of the total amount for each delay of 2 weeks from the 15 October 2005.
Article 8 
The conversion rate for applications submitted in national currency in month ‘n’ shall be that of the 10th day of month ‘n+1’ or for the first preceding day for which a rate is quoted.
Article 9 
This Decision shall apply from 1 October 2004.
Article 10 
This decision is addressed to the Member States.
Done at Brussels, 22 September 2004.
For the Commission
David BYRNE
Member of the Commission
ANNEX I
(EUR)
Member State Amount
Austria (AT) 59 368
Belgium (BE) 42 312
Cyprus (CY) 5 412
Denmark (DK) 31 160
Estonia (EE) 4 920
Finland (FI) 55 432
France (FR) 81 672
Germany (DE) 87 412
Greece (EL) 38 048
Hungary (HU) 45 264
Ireland (IE) 28 208
Italy (IT) 70 684
Latvia (LV) 3 280
Lithuania (LT) 3 280
Luxembourg (LU) 3 280
Netherlands (NL) 77 736
Poland (PL) 72 160
Portugal (PT) 28 208
Slovenia (SI) 17 056
Spain (ES) 80 360
Sweden (SE) 34 440
United Kingdom (UK) 71 504
Slovak Republic (SK) 6 560
Czech Republic (CZ) 14 760
Malta (MT) 3 280
Total 965 796
ANNEX II
Reporting period from to
Statement on costs subject to Community assistance incurred for the study
Reference number of Commission Decision providing financial assistance:

Costs incurred related to functions at/by Number of tests Total costs for testing incurred during the reporting period (national currency)
Bacteriology for Salmonella spp.  
Serotyping salmonella isolates  
WE CERTIFY THAT


— the above costs were genuine and incurred in connection with the tasks defined in the Decision and were essential to the sound performance of those tasks,
— all the documents supporting the costs are available for audit purposes.

Date:

Person financially responsible:

Signature
